3Kothavade R J,Panthaki MH.Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice[J].J Med Microbiol,1998,47(2):99-102.
7Fekete-Forgacs K,Gyure L,Lenkey B.Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans[J].Mycoses,2000,43(7-8):273-279.
2Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans[J]. Infect Immun, 1995, 63(5): 1993-1998.
3Silverman DJ, Santucci LA, Meyers N, et al. Penetration of host cells by Rickettsia rickettsii appears to be mediated by a phospholipase of rickettsial origin[J]. Infect Immun, 1992, 60(7):2733-2740.
4Leidich SD, Ibrahim AS, Fu Y, et al. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans[J]. J Biol Chem, 1998, 273(40): 26078-26086.
5Ibrahim AS, Mirbod F, Filler SG, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun, 1995,63(5): 1993-1998.
6Ghannoun MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev, 2000 , 13( 1 ): 122-143.
7Sugiyama Y, Nakashima S, Mirbod F, et al. Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans. Med Mycol,1999 ,37(1) :61-67.
8Leidich SD, Ibrahim AS, Fu Y, et al. Cloning and disruption of caPLB1,a phospholipase B gene involved in the pathogenicity of Candida albicans.J Biol Chem, 1998,273(40) :26078-26086.
9Bennett DE, McCreary CE, Coleman DC. Genetic characterization of a phospholipase c gene from Camclida albicans: presence of homologous sequences in Candida species other than Candida albicans . Microbiology,1998,144(Pt 1) :55-72.
10Kanoh H, Nakashima S, Zhao Y, et al. Molecular cloning of a gene encoding phospholipase D from the pathogenic and dimorphic fungus, Candida albicans. Biochim Biophys Acta, 1998,1398(3) :359-364.
4Hazen KC, Baron E, Colombo AL, et al. Comparison of the Suscepti- bilities of Candida spp to fluconazole and voriconazole in a 4-year global evaluation using disk diffusion[J]. J Clin Microbio, 2003, 41 (12): 5623 - 5632.
5Slavin MA, Sorrell TC, Marriott D, et al. Candidaemia in adult cancer patients : risks for fluconazole-resistant isolates and death [ J ]. J Antimi- crob Chemother, 2010, 65(5) : 1042 -1051.
6Wu T, Katherine W, Steven F, et al. Enhanced extracellular produc- tion of aspartyl proteinase a virulence factor, by Candida albicans iso- lates following growth in subinhibitory concentrations of flanonazole [J]. Antimicrob Chemother, 2000, 44 (5) : 1200 - 1208.
